180 related articles for article (PubMed ID: 37774045)
1. Association of VEGF-116G/A Promoter Polymorphism with Esophageal Cancer Risk: A Case-Control study and an Updated Meta-Analysis on Gastrointestinal Tract Cancers.
Mahajan D; Sambyal V; Uppal MS; Sudan M; Guleria K
Asian Pac J Cancer Prev; 2023 Sep; 24(9):2951-2962. PubMed ID: 37774045
[TBL] [Abstract][Full Text] [Related]
2.
Mahajan D; Sambyal V; Uppal MS; Sudan M; Guleria K
Genet Test Mol Biomarkers; 2024 May; 28(5):176-188. PubMed ID: 38597641
[TBL] [Abstract][Full Text] [Related]
3. Impact of VEGFA promoter polymorphisms on esophageal cancer risk in North-West Indians: a case-control study.
Guleria K; Kaur S; Mahajan D; Sambyal V; Sudan M; Uppal MS
Genes Genomics; 2022 Aug; 44(8):923-936. PubMed ID: 35767183
[TBL] [Abstract][Full Text] [Related]
4.
Bali JS; Sambyal V; Guleria K; Mehrotra S; Singh NR; Uppal MS; Manjari M; Sudan M
J Cancer Res Ther; 2022 Dec; 18(Supplement):S273-S279. PubMed ID: 36510976
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India.
Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
Tumour Biol; 2014 Nov; 35(11):11171-81. PubMed ID: 25106408
[TBL] [Abstract][Full Text] [Related]
6. Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis.
Zhang XW; Li J; Jiang YX; Chen YX
World J Gastroenterol; 2017 Mar; 23(12):2234-2245. PubMed ID: 28405152
[TBL] [Abstract][Full Text] [Related]
7. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
Song Y; Yang Y; Liu L; Liu X
Gene; 2019 May; 698():186-197. PubMed ID: 30849545
[TBL] [Abstract][Full Text] [Related]
8. Relationship between apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal cancer risk: An updated meta-analysis.
Dai ZJ; Shao YP; Kang HF; Tang W; Xu D; Zhao Y; Liu D; Wang M; Yang PT; Wang XJ
World J Gastroenterol; 2015 Apr; 21(16):5081-9. PubMed ID: 25945024
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the association between ZBTB20 rs9841504 polymorphism and gastric and esophageal cancer susceptibility: a meta-analysis.
Shi J; Li W; Ding X
Int J Biol Markers; 2017 Mar; 32(1):e96-e101. PubMed ID: 27646774
[TBL] [Abstract][Full Text] [Related]
10. An Association and Meta-Analysis of Esophageal Squamous Cell Carcinoma Risk Associated with PLCE1 rs2274223, C20orf54 rs13042395 and RUNX1 rs2014300 Polymorphisms.
Nariman-Saleh-Fam Z; Saadatian Z; Nariman-Saleh-Fam L; Ouladsahebmadarek E; Tavakkoly-Bazzaz J; Bastami M
Pathol Oncol Res; 2020 Apr; 26(2):681-692. PubMed ID: 30666517
[TBL] [Abstract][Full Text] [Related]
11. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies.
Moazeni-Roodi A; Ghavami S; Hashemi M
Microrna; 2019; 8(2):94-100. PubMed ID: 30514199
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha promoter polymorphism 308 G/A is not significantly associated with esophageal cancer risk: a meta-analysis.
Luo M; Yang Y; Luo D; Liu L; Zhang Y; Xiao F; Yang J; Zhang C; Fu S; Luo Z
Oncotarget; 2016 Nov; 7(48):79901-79913. PubMed ID: 27821804
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.
Hong TT; Zhang RX; Wu XH; Hua D
Mol Biol Rep; 2012 May; 39(5):5283-9. PubMed ID: 22167330
[TBL] [Abstract][Full Text] [Related]
14. Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis.
Chen CH; Ho CH; Kuan-Hua Huang S; Shen CH; Wu CC; Wang YH
Cytokine; 2020 Jul; 131():155112. PubMed ID: 32361400
[TBL] [Abstract][Full Text] [Related]
15. PLCE1 rs2274223 A>G polymorphism and cancer risk: a meta-analysis.
Umar M; Upadhyay R; Mittal B
Tumour Biol; 2013 Dec; 34(6):3537-44. PubMed ID: 23797815
[TBL] [Abstract][Full Text] [Related]
16. Novel functional variants locus in PLCE1 and susceptibility to digestive tract cancer in the Chinese population: a meta-analysis.
Duan F; Song C; Dai L; Cui S; Zhang X; Zhao X
Int J Biol Markers; 2014 Dec; 29(4):e301-9. PubMed ID: 24874112
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis.
Deng ZC; Cao C; Yu YM; Ma HY; Ye M
Tumour Biol; 2014 Mar; 35(3):1805-11. PubMed ID: 24146275
[TBL] [Abstract][Full Text] [Related]
18. The association between vascular endothelial growth factor (VEGF) +405G>C genetic polymorphism and endometriosis.
Fang F; Gong L; Wang X; Zhang L
Exp Biol Med (Maywood); 2015 Sep; 240(9):1177-82. PubMed ID: 25573961
[TBL] [Abstract][Full Text] [Related]
19. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
20. Association of hypoxia inducible factor 1-Alpha gene polymorphisms with multiple disease risks: A comprehensive meta-analysis.
Harun-Or-Roshid M; Ali MB; Jesmin ; Mollah MNH
PLoS One; 2022; 17(8):e0273042. PubMed ID: 35972942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
